Results 151 to 160 of about 1,086,070 (250)

Management of <i>Mycobacterium bovis</i> Meningitis: The Case for Adjunctive Empirical Therapy. [PDF]

Open Forum Infect Dis
Birabaharan M, Cowell AN.
europepmc   +1 more source

Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia

, 2017
Demelash Assefa,1 Berhanu Seyoum,2 Lemessa Oljira2 1KNCV Tuberculosis Foundation, Addis Ababa, 2School of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia Abstract: Multidrug-resistant tuberculosis (MDR-TB) has ...
Assefa D, Seyoum B, Oljira L
core  

Epidemiologic and clinical characteristics of <i>Mycobacterium tuberculosis</i> infection in Guangxi, China, 2018-2023: a retrospective study. [PDF]

Front Cell Infect Microbiol
Bi D, Chen C, Yu H, Ma Q, Luo X, He H, Tang X, Liang C, Wen L, Xi S, Liu Z, Huang W, Long Q, Su H, Luo X, Wei W, Pang Z, Huang N, Wei Z, Shao H, Xie Z.   +20 more
europepmc   +1 more source

Drug-resistant tuberculosis in conflict zones: a neglected global emergency. [PDF]

J Clin Tuberc Other Mycobact Dis
Abdi YH, Bashir SG.
europepmc   +1 more source

Real-world treatment outcomes and adverse events during BPaLM therapy for rifampicin-resistant TB. [PDF]

IJTLD Open
Choong CV, Soh EP, Ong YY, Tay JX, Khoong CHL, Lau AEL, Chee CBE.   +6 more
europepmc   +1 more source

Risk factors and prediction modeling for drug-resistant tuberculosis in Shenzhen: a 9-year retrospective study. [PDF]

Front Public Health
Wang J, Chen M, Zha X, Ding F, Zhang H, Lu SH, Liu X.   +6 more
europepmc   +1 more source

The threat of multidrug-resistant tuberculosis

Journal of Global Infectious Diseases, 2018
openaire   +3 more sources

What is new in tuberculosis? [PDF]

Clin Med (Lond)
Myat Y, Cerrone M, Kon OM.
europepmc   +1 more source

Characteristics of Primary and acquired multidrug-resistant tuberculosis patients in West Java, Indonesia. [PDF]

IJID Reg
Santoso P, Khairani AP, Buchori E, Chaidir L, Soeroto AY.   +4 more
europepmc   +1 more source

Global and Regional Patterns of Drug Resistance and Treatment Regimens in Spinal Tuberculosis: A Systematic Review and Meta-Analysis. [PDF]

Global Spine J
Rajasekaran S, Gurusamy G, Shetty AP, Kanna RM, Bicholkar AU, Sathwik N, Bindu Vasanthi N, Gogul SP, Gandhi AP, Vv G, Kaviprawin M.   +10 more
europepmc   +1 more source